首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1672726

癌症治疗市场按分销管道、药物类型、癌症类型、治疗方法、给药途径和地区划分

Oncology Drugs Market, By Distribution Channel, Drug Type, Cancer Type, By Therapy, By Route of Administration, By Geography

出版日期: 2025年02月14日 | 出版商:

Coherent Market Insights | 英文 188 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球抗癌药物市场规模估计为 2,612.2 亿美元，预计到 2032 年将达到 6,073.6 亿美元，2025 年至 2032 年的复合年增长率为 12.8%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	2612.2亿美元
效能资料	2020-2024	预测期	2025-2032
预测期：2025 年至 2032 年复合年增长率	12.80％	2032 年金额预测	6073.6亿美元

图。

抗癌药是指用于治疗癌性肿瘤的药物。由于各种癌症发病率的上升，全球抗癌药物市场在过去几年一直稳定成长。根据世界卫生组织 (WHO) 的数据，自 2000 年以来，全球癌症发生率几乎翻了一番，预计到 2040 年全球整体发生率将增加 50%。肺癌、结肠癌、乳癌和摄护腺癌等癌症发生率上升是推动抗癌药物需求的主要因素。此外，老年人口的增加以及吸烟、饮酒、饮食不良、缺乏运动等生活习惯的改变也在增加罹患癌症的风险，从而增加癌症治疗药物的销售量。大量新型药物分子和治疗方法以及标靶治疗的出现进一步推动了市场扩张。然而，高昂的治疗费用仍是阻碍抗癌药物广泛使用的瓶颈。

市场动态

全球抗癌药物市场受到世界各地各种癌症发生率不断上升的推动。根据提供全球癌症统计数据的基于网路的互动式平台 GLOBOCAN 的数据，2020 年全球将有约 1,930 万例新发癌症病例和 1,000 万人死亡。肺癌仍然是癌症死亡的主要原因。标靶治疗的需求不断增长以及学名药的易得性为市场提供了巨大的成长机会。然而，严格的监管措施、市场开发的高研发成本以及临床测试的高失败率是限制市场成长的一些因素。此外，重磅药物专利到期也对各大公司的收益负面影响。随着人们认识的提高、医疗支出的增加以及对优质抗癌药物的需求，亚太地区的新兴市场正以巨大的潜力开闢新的道路。

研究的主要特点

本报告对全球肿瘤药物市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球抗癌药物市场的主要企业已根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行了分析。
本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
本报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过全球抗癌药物市场分析中使用的各种策略矩阵更轻鬆地做出决策。

热图分析
公司简介
- Pfizer Inc.
- Novartis AG
- AstraZeneca PLC
- Gilead Sciences Inc.
- Bristol-Myers Squibb
- Amgen Inc.
- Sanofi AG
- F. Hoffmann-La Roche AG
- Merck &Co.
- Bristol-Myers Squibb Company
- Regeneron Pharmaceuticals Inc.
- GSK plc
- Ono Pharmaceutical Co., Ltd.
- Eli Lilly and Company
- BeiGene LTD
- Astellas Pharma Inc.
- AbbVie Inc.
- Takeda Pharmaceutical Company
- Daiichi Sankyo

第 12 章分析师观点

兴衰
一致的机会地图

第十三章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI2332

Global Oncology Drugs Market is estimated to be valued at USD 261.22 Bn in 2025 and is expected to reach USD 607.36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 261.22 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.80%	2032 Value Projection:	USD 607.36 Bn

Figure. Oncology Drugs Market Share (%), By Region 2025

Oncology drugs refer to medications that are used for treating cancerous tumors. The global oncology drugs market has been witnessing steady growth over the past few years owing to the rising prevalence of various types of cancers. According to the World Health Organization, the cancer burden has nearly doubled since 2000 and is expected to grow by 50% globally by 2040. The increasing incidences of lung cancer, colorectal cancer, breast cancer, and prostate cancer are the major factors fueling the demand for oncology drugs. Furthermore, the growing geriatric population and changing lifestyle habits such as tobacco smoking, alcohol consumption, poor diet, and lack of physical activity have also raised the risk of developing cancer which has augmented the sales of oncology medications. A robust pipeline of novel drug molecules and therapies along with the emergence of targeted therapies are further catalyzing market expansion. However, high treatment cost remains a bottleneck, restraining the broader adoption of cancer medications.

Market Dynamics:

The global oncology drugs market is driven by the rising prevalence of various cancer types worldwide. As per GLOBOCAN, an interactive web-based platform presenting global cancer statistics, there were around 19.3 million new cancer cases and 10 million cancer deaths globally in 2020. Lung cancer remains the leading cause of cancer death. The increasing demand for targeted therapies and easy availability of generic medications are providing huge growth opportunities in the market. However, factors such as stringent regulatory policies, high R&D costs involved in drug development, and frequent drug failures in clinical trials are impeding the market growth. Furthermore, patent expiry of blockbuster drugs is negatively impacting the revenues of major players. Nonetheless, emerging markets in Asia Pacific are opening up new avenues by offering potential future opportunities driven by growing awareness, healthcare spending, and demand for quality cancer treatment.

Key Features of the Study:

This report provides an in-depth analysis of the global oncology drugs market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global oncology drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes Pfizer Inc., Novartis AG, AstraZeneca PLC, Gilead Sciences Inc., Amgen Inc., Sanofi AG, F. Hoffmann-La Roche AG, Merck & Co., Bristol-Myers Squibb Company, Regeneron Pharmaceuticals Inc., GSK plc, Ono Pharmaceutical Co., Ltd., Eli Lilly and Company, BeiGene LTD, Astellas Pharma Inc., AbbVie Inc., Takeda Pharmaceutical Company, and Daiichi Sankyo
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global oncology drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oncology drugs market

Market Segmentation

Drug Type
- Cytotoxic Drugs
- Alkylating Agents
- Antimetabolites
- Others
- Targeted Drugs
- Monoclonal Antibodies
- Tyrosine Kinase Inhibitors
- Others
- Hormonal Drugs
- Ovarian Function Blockers
- Estrogen Production Blockers
- Others
Cancer Type:
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Blood Cancer
- Bladder Cancer
- Other
Therapy:
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Others
Route of Administration:
- Oral
- Parental
- Intramuscular
- Intravenous
- Subcutaneous
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer Inc.
- Novartis AG
- AstraZeneca PLC
- Gilead Sciences Inc.
- Amgen Inc.
- Sanofi AG
- F.Hoffmann-La Roche AG
- Merck & Co.
- Bristol-Myers Squibb Company
- Regeneron Pharmaceuticals Inc.
- GSK plc
- Ono Pharmaceutical Co., Ltd.
- Eli Lilly and Company
- BeiGene LTD
- Astellas Pharma Inc.
- AbbVie Inc.
- Takeda Pharmaceutical Company
- Daiichi Sankyo

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Preview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Cancer Type
- Market Snapshot, By Therapy
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Pipeline Analysis
Patent Expiry List (2018-2031)
Investments for R&D
Reimbursement Scenario
Mergers & Acquisitions
Collaborations
Epidemiology
PEST Analysis

4. Global Oncology Drugs Market - Impact of Coronavirus (COVID-19) Pandemic:

Overall Impact
COVID-19 Impact on the Market

5. Global Oncology Drugs Market, By Drug Type, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cytotoxic Drug
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Alkylating Agents
Antimetabolites
Others
Targeted Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Monoclonal Antibodies
Tyrosine Kinase Inhibitors
Others
Hormonal Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Ovarian Function Blockers
Estrogen Production Blockers
Others
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

6. Global Oncology Drugs Market, By Cancer Type,2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Breast Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Prostate Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Blood Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Bladder Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

7. Global Oncology Drugs Market, By Therapy, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Targeted Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

8. Global Oncology Drugs Market, By Route of Administration, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Parental
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Intramuscular
- Intravenous
- Subcutaneous

9. Global Oncology Drugs Market, By Distribution Channel, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

10. Global Oncology Drugs Market, By Region, 2020 - 2032, (USD BN)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
Middle East
Africa

11. Competitive Landscape

Heat Map Analysis
Company Profile
- Pfizer Inc.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Novartis AG
- AstraZeneca PLC
- Gilead Sciences Inc.
- Bristol-Myers Squibb
- Amgen Inc.
- Sanofi AG
- F. Hoffmann-La Roche AG
- Merck & Co.
- Bristol-Myers Squibb Company
- Regeneron Pharmaceuticals Inc.
- GSK plc
- Ono Pharmaceutical Co., Ltd.
- Eli Lilly and Company
- BeiGene LTD
- Astellas Pharma Inc.
- AbbVie Inc.
- Takeda Pharmaceutical Company
- Daiichi Sankyo

12. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

癌症治疗市场按分销管道、药物类型、癌症类型、治疗方法、给药途径和地区划分